Additional immunophenotypic markers useful in lineage assignment or subtyping of AML: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
!colspan="2" <span style="font-size:100%; colour:white; text-align:left; border: 1px solid black; background:lightgrey">|Additional markers that may support granulocytic maturation'''</span><span style="font-size:90%; text-align:left; background:white"> | !colspan="2" <span style="font-size:100%; colour:white; text-align:left; border: 1px solid black; background:lightgrey">|Additional markers that may support granulocytic maturation'''</span><span style="font-size:90%; text-align:left; background:white"> | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" | | |colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |Standard markers in AML generally allow assignment for granulocytic cases, other markers may be less specific | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |'''[[CD11b]]''' | |colspan="1" style = "font-size:90%; color:black;" |'''[[CD11b]]''' | ||
Revision as of 18:06, 20 December 2023
Table: Marker patterns that can contribute to diagnosis or subtyping in less common cases
| Additional markers that may support granulocytic maturation | |
|---|---|
| Standard markers in AML generally allow assignment for granulocytic cases, other markers may be less specific | |
| CD11b | A marker of both granulocytic and monocytic maturation, this marker has previously been associated with less good outcome in a number of studies |
| point 2 | |
| Addtional features of monocytic differentiation | |
| CD11c | This marker is most associated with monocytic maturation in AML being fairly well corellated with CD11B, but overall probably less specific for monocytic differentiation that CD14 |
| CD14 | Primarily a marker of monocytic maturation in AML, seen most often in more differentiated forms, when present CD14 be considered a strong indicator of monocytic phenotype. |
| CD64 | A good lineage marker for monocytic differentiation in AML, expressed in both monoblastic and monocytic forms, not fully sepicific when expressed at lower levels. |
| point 3 | |
| Features associated with erythroid differentiation | |
| Most often CD34, CD45 and HLA-DR are weak or negative, although CD117 and CD36 are generally expressed. There may be some expression of platelet markers in some cases. | |
| CD71 | Frequently expressed though not fully lineage specific |
| CD235 | A good marker of erythroid differentiation but acquired late and therefore may not be expressed |
| point 4 | |
| Features associated with megakaryocytic differentiation | |
| Most often CD34, CD45 and HLA-DR are weak or negative, although CD13 and CD33 may be expressed | |
| CD41 | Platelet glycoprotein IIbIIIa |
| CD61 | Platelet glycoprotein IIIa |
| CD36 | Relatively non-specific (seen in erythroid and monocytic leukaemias) but often strongly expressed
|